David A. Siegel Compugen LTD Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Compugen LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 35,784 shares of CGEN stock, worth $64,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,784
Previous 18,484
93.59%
Holding current value
$64,769
Previous $33,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CGEN
# of Institutions
80Shares Held
13.4MCall Options Held
44.9KPut Options Held
8.1K-
Silverarc Capital Management, LLC1.62MShares$2.94 Million0.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$2.31 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$1.98 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.85 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$1.79 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $157M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...